You will receive a message with a link to the case study at the email address provided.
Help support better patient care and better manage costs — now.
Rule in or rule out myocardial infarction (MI) earlier to optimize patient care and help improve the financial, operational and clinical metrics associated with chest pain assessment. With high-sensitive* Elecsys® Troponin T Gen 5 STAT, organizations can:
Detect previously undetectable levels of troponin1 to help reduce the risk of sending home the wrong patient.
Be confident that a negative is a negative with TnT Gen 5 STAT’s superior NPV of 99.3% at 3 hours.2
Discover the impact of TnT Gen 5 STAT. Click to explore.
Emergency Department Clinicians
TnT Gen 5 STAT: One proven way to optimize cardiac care and avoid unnecessary costs.
Helps rule in or rule out MI earlier. NPV 99.3% at three hours and 100% at six hours.2
Treat patients sooner. Nine-minute assay results2 help speed decision-making, which may help clinicians start treatment sooner.
Comprehensive support helps simplify adoption. Over 400 sites are live with TnT Gen 5 STAT. Roche is actively assisting 110 sites in the transition to TnT Gen 5 STAT, while an additional 60 sites are currently being coached on the go-live process.
Quality Managers
Waiting can cost more than minutes. Help improve cardiac care and the bottom line with TnT Gen 5 STAT.
Helps avoid unnecessary costs.3 Reducing ED wait time can help improve value-based quality measures.
Tangible savings. Roche can show the impact of TnT Gen 5 STAT tailored to a specific organization.
Supports requirements for Chest Pain Center Accreditation.
Administrators
TnT Gen 5 STAT can help improve patient care and avoid unnecessary costs.3
Helps avoid unnecessary costs.3 Reducing ED wait time can help improve value-based quality measures.
Tangible savings. Roche can show the impact of TnT Gen 5 STAT tailored to a specific organization.
Supports requirements for Chest Pain Center Accreditation.
Comprehensive support helps simplify adoption. Over 400 sites are live with TnT Gen 5 STAT. Roche is actively assisting 110 sites in the transition to TnT Gen 5 STAT, while an additional 60 sites are currently being coached on the go-live process.
Cardiologists
TnT Gen 5 STAT is trusted by the number one and number two Best Hospitals for Cardiology.4
Confidently get patients with chest pain the care they need sooner. Detect previously undetectable levels of troponin1 to help reduce the risk of sending home the wrong patient.
Shown to aid in diagnosis of >2x more MIs at three hours than previous generation of Tn.2
Ruling in or out earlier1 helps optimize patient care and helps achieve value-based care demands.
Lab Leaders
TnT Gen 5 STAT supports workflow needs for speed and accuracy in the diagnosis of MIs.
Treat patients sooner. Nine-minute assay results2 help speed decision-making, which may help clinicians start treatment sooner.
Shown to aid in diagnosis of >2x more MIs at three hours than previous generation of Tn.2
Helps rule in or rule out MI earlier. NPV 99.3% at three hours and 100% at six hours.2
Comprehensive support helps simplify adoption. Over 400 sites are live with TnT Gen 5 STAT. Roche is actively assisting 110 sites in the transition to TnT Gen 5 STAT, while an additional 60 sites are currently being coached on the go-live process.
Want to learn more about TnT Gen 5 STAT's medical value?
